N-type calcium channel blockers

Details for Australian Patent Application No. 2005206226 (hide)

Owner Neuromed Technologies, Inc.

Inventors Snutch, Terrance P.; Pajouhesh, Hossein; Ding, Yanbing; Pajouhesh, Hassan

Agent Blake Dawson Waldron Patent Services

Pub. Number AU-A-2005206226

PCT Pub. Number WO2005/070919

Priority 10/763,974 22.01.04 US

Filing date 21 January 2005

Wipo publication date 4 August 2005

International Classifications

C07D 207/30 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4439 (2006.01)

C07D 207/14 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/26 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/070919 Priority application(s): WO2005/070919

19 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005206227-Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events

2005206224-Tamping labeler